Cargando…
Response to the Letter to the Editor Regarding “Intraclass Difference in Pneumonia Risk with Fluticasone and Budesonide in COPD: A Systematic Review of Evidence from Direct-Comparison Studies” [Response to Letter]
Autores principales: | Lodise, Thomas P, Sethi, Sanjay |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8121281/ https://www.ncbi.nlm.nih.gov/pubmed/34007165 http://dx.doi.org/10.2147/COPD.S315195 |
Ejemplares similares
-
Intraclass Difference in Pneumonia Risk with Fluticasone and Budesonide in COPD: A Systematic Review of Evidence from Direct-Comparison Studies
por: Lodise, Thomas P, et al.
Publicado: (2020) -
Reply to: “Intraclass Difference in Pneumonia Risk with Fluticasone and Budesonide in COPD: A Systematic Review of Evidence from Direct-Comparison Studies” [Letter]
por: Barnes, Neil C, et al.
Publicado: (2021) -
Letter to the Editor, International Journal of COPD [Response to Letter]
por: Llordés, Montserrat, et al.
Publicado: (2020) -
Letter to the editor response
por: Krawiec, Conrad, et al.
Publicado: (2022) -
Letter to the Editor Response Regarding “Research Equity in Otolaryngology–Head and Neck Surgery”
por: Patterson, Rolvix Harlan, et al.
Publicado: (2021)